Calculate (Medical Calculator)

Read time: 1 min
Miniatura app: 
Valutazione media per questa versione: 
4,5/5 Apple (45 ratings) and 4,6/5 AndroidMarket (832 ratings)
Valutazione di Scienza in rete: 
utile
Dimensione: 
10.3 Mb Apple and 5,8 Mb Android
Prezzo: 
free
Titolo: 
Calculate (Medical Calculator) by QxMD
16/12/2011 Apple and 19/01/2012 Android
Autore: 
QxMD Medical Software
Anteprima: 
Calculate (Medical Calculator) is a clinical calculator for iPhone, iPad, iPod Touch, BlackBerry and Android with more than 150 unique calculators and tools.
Lingua: 
English

Calculate (Medical Calculator) is a clinical calculator for iPhone, iPad, iPod Touch, BlackBerry and Android with more than 150 unique calculators and tools.
These calculators are grouped by specialty, but the “All” button on the bottom index bar allows more convenient searching.
Calculate (Medical Calculator) offer also the ability to designate calculators as “favorites” and stores recently used calculators.
The menu screens and general interface experience is relatively simple allowing a quick use.

Calculate (Medical Calculator) is freely available to the medical community.

Video tutorial and previews of the app:

[video:http://www.youtube.com/watch?v=NW4KPIHw5vg]

[video:http://www.youtube.com/watch?v=hRHicvwnrdI]

Apple:

Calculator Apple 1 Calculator Apple 2 Calculator Apple 3 Calculator Apple 4 Calculator Apple 5 Calculator Apple 6

Android:

Calculate Android 1 Calculate Android 2

altri articoli

Research agency: our proposals to the government and parliament

Gruppo 2003: It is important that the Research Agency is transparent and independent from politics, starting from the choice of its governing bodies.

The Italian Government has finally proposed a National Agency for Research, which has been advocated for many years by the Gruppo 2003, a charity of Italian highly Cited scientists focused on Italian research policy. For the moment, information on the characteristics of the Agency is contained in Article 28 of the Draft Budget Law for 2020, which will be discussed in the Chambers in the coming days.